HUTCHMED (China) Limited (AIM:HCM)
London · Delayed Price · Currency is GBP · Price in GBX 215.00
-0.50 (-0.23%)
Nov 25, 2025, 2:19 PM GMT+1
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of 1.85 billion as of November 25, 2025. Its market cap has decreased by -21.49% in one year.
Market Cap
1.85B
Enterprise Value
938.00M
Revenue
439.54M
Ranking
n/a
PE Ratio
5.57
Stock Price
215.00
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 128.29M to 1.85B, an increase of 1,343.55%. That is a compound annual growth rate of 14.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 1.86B | -7.16% |
| Dec 31, 2024 | 2.01B | -16.84% |
| Dec 29, 2023 | 2.42B | 8.25% |
| Dec 30, 2022 | 2.23B | -50.85% |
| Dec 31, 2021 | 4.54B | 36.26% |
| Dec 31, 2020 | 3.33B | 31.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.31B |
| GSK plc | 71.84B |
| Haleon | 33.59B |
| Smith & Nephew | 10.61B |
| ConvaTec Group | 4.65B |
| Hikma Pharmaceuticals | 3.53B |
| Genus | 1.65B |
| Oxford Nanopore Technologies | 1.27B |